Annual report pursuant to Section 13 and 15(d)


12 Months Ended
Dec. 31, 2019
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net loss $ (1,000) $ (1,460,914)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account   (11,254)
Changes in operating assets and liabilities:    
Prepaid expenses 0 (124,766)
Accrued expenses 1,000 1,162,558
Net cash used in operating activities   (434,376)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account   (230,000,000)
Net cash used in investing activities   (230,000,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of Class B common stock to Sponsor   25,000
Proceeds from sale of Units, net of underwriting discounts paid   225,400,000
Proceeds from sale of Private Placement Units   6,500,000
Proceeds from promissory note - related party   140,671
Repayment of promissory note - related party   (140,671)
Payment of offering costs   (473,487)
Net cash provided by financing activities   231,451,513
Net Change in Cash   1,017,137
Cash - Beginning 0 0
Cash - Ending 0 1,017,137
Non-cash investing and financing activities:    
Initial classification of common stock subject to possible redemption   218,395,060
Change in value of common stock subject to possible redemption   (1,460,920)
Deferred underwriting fee payable   8,050,000
Offering costs included in accrued offering costs $ 26,171 $ 5,450